Gut bacteria therapy shows promise for ulcerative colitis in new trial
Disease control
Recruiting now
This study tests a new medicine called MH002, which contains live bacteria that may help repair the gut in people with mild-to-moderate ulcerative colitis. About 204 adults whose symptoms are not well controlled by standard treatment will receive either MH002 or a placebo. The go…
Phase: PHASE2 • Sponsor: MRM Health NV • Aim: Disease control
Last updated May 26, 2026 12:01 UTC